Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the world and one of the leading indications for liver transplantation. It is one of the many …

Nonalcoholic fatty liver disease (NAFLD) is a complex metabolic-inflammatory disease
associated with poor outcomes and decreased quality of life. NAFLD is overrepresented in …

Background Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis
in over 5% of the parenchyma in the absence of excessive alcohol consumption. It is more …

Non-alcoholic fatty liver disease (NAFLD) and its complication non-alcoholic steatohepatitis
(NASH) are important causes of liver disease worldwide. Recently, a significant association …

Nonalcoholic fatty liver disease (NAFLD), also recently referred as metabolic (dysfunction)-
associated fatty liver disease (MAFLD), is characterized by hepatocyte steatosis in the …

Non-alcoholic fatty liver disease (NAFLD) constitutes the most common liver disease
worldwide, and is frequently linked to the metabolic syndrome. The latter represents a …

Major depressive disorder (MDD), which is highly associated with non-alcoholic fatty liver
disease (NAFLD), has complex pathogenic mechanisms. However, a limited number of …

Patients with severe mental illness have increased mortality, often linked to cardio-metabolic
disease. Non-alcoholic fatty liver disease (NAFLD) incidence is higher in patients with …

Non-alcoholic fatty liver disease (NAFLD) has emerged as the hepatic component of the
metabolic syndrome and now seemingly affects one-fourth of the world population. Features …

Background Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease,
affecting 25-30% of the general population globally. The condition is even more prevalent in …